CHEK2 and breast cancer: A total of 195 patients were selected based on family history or early age of breast cancer diagnosis and no mutation in BRCA, CHEK2, NBN, or PALB2. Multiple rare truncating variants were found in RECQL, a previously identified cancer-related gene, in both populations.